| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Professional | $607,476.55 | $654,925.00 | $654,925.00 | |
Providence
| Professional | $604,637.39 | $604,637.39 | $788,657.46 |
Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Professional | $607,476.55 | $654,925.00 | $654,925.00 | |
Providence
| Professional | $604,637.39 | $604,637.39 | $788,657.46 |